Funding search · EIN 137184401 · New York, NY

The Leona M and Harry B Helmsley

Name: The Leona M and Harry B Helmsley grants, 2021–2024
Creator: PaperOrbit
License: https://www.irs.gov/charities-non-profits/exempt-organization-public-disclosure-and-availability-requirements

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

2,251
grants reported: $1.69B
total given: 2021–2024
filing years: $393,039
median grant

Based on grants this organization reported to the IRS for tax years 2021–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

disease crohns health diabetes center type ultrasound care

Funder website ↗Full IRS filings ↗How this is built Report an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Where the money goes

Type 1 diabetes care, prevention trials, and global access
Crohn's disease mechanism, diagnostics, and therapeutic research
Rural US hospital equipment and capital, especially Upper Midwest and Hawaii
Israeli hospital construction and university science buildings
Sub-Saharan Africa health systems, WASH, and maternal-child care
Emergency and telehealth systems: stroke, ECMO, point-of-care ultrasound

Typical grant

Median grant is about $393,000, with the middle half between $156,000 and $927,000. The seven-figure checks go to two things: bricks and equipment (hospital wings in Israel, cancer centers in Hawaii, ultrasound fleets across North Dakota and Minnesota) and multi-year research or scale-up commitments in T1D and Crohn's, often $1.5M to $5M. Repeat giving is the norm, and the same recipient frequently appears two or three times in one year as a multi-payment award.

Their words

Phrases from their own grant descriptions, worth speaking back to them.

“T1D”
“Crohn's disease”
“ultrasound initiative”
“scaling”
“quality improvement”
“access to primary care”

Positioning adjacent work

Frame diabetes work as T1D specifically, tied to outcomes, registries, or quality improvement collaboratives.
For Crohn's, propose mechanistic or precision-diagnostic science with a defined trial or dataset endpoint.
Rural health proposals should name equipment, training, and geography: Dakotas, Minnesota, Montana, Hawaii.
Ask $1.5M to $3M multi-year for research; capital requests run $2M to $5M.

Worth knowing: Giving is concentrated in a small set of long-term partners (T1D Exchange, Blue Circle Health, Helmholtz Zentrum Munchen, Clalit, Billings Clinic, American Heart Association) and reads as relationship-driven and invited rather than competitive. Beyond the coastal research hubs in NY, MA, and CA, the money follows named geographies: rural Upper Midwest, Hawaii, Israel, and Ghana-centered Africa work.

152 grants matching “type” · $97.3M

$1.9M
Helmholtz Zentrum Munchen (Gmbh) · 2024
Continuation of the gppad-02-study identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$1.9M
Helmholtz Zentrum Munchen (Gmbh) · 2024
The gppad-05 study anti-viral action against type 1 diabetes autoimmunity (avant1a)
$1.9M
Vayu Health · Portola Valley, CA · 2024
Vayu health phase 2 - scale and spread of value based payment ecosystem for medicaid beneficiaries living with type 1 and type 2 diabetes
$1.9M
New Venture Fund · Washington, DC · 2024
Type 1 diabetes camps project (2025-2028)
$1.9M
Vayu Health · Portola Valley, CA · 2024
Vayu health phase 2 - scale and spread of value based payment ecosystem for medicaid beneficiaries living with type 1 and type 2 diabetes
$1.3M
Helmholtz Zentrum Munchen (Gmbh) · 2024
Continuation 2 of the gppad-02-study identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$1.3M
Helmholtz Zentrum Munchen (Gmbh) · 2024
The gppad-04 study supplementation with b. Infantis for mitigation of type 1 diabetes autoimmunity (sint1a)
$1.3M
Vayu Health · Portola Valley, CA · 2024
Vayu health phase 2 - scale and spread of value based payment ecosystem for medicaid beneficiaries living with type 1 and type 2 diabetes
$1.2M
Michigan State University · East Lansing, MI · 2024
A c-peptide complex for improved glucose metabolism in people with type 1 diabetes
$1.2M
Helmholtz Zentrum Munchen (Gmbh) · 2024
Continuation 2 of the gppad-02-study identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$1.1M
Universite De Geneve · 2024
Preclinical testing of s100a9 to improve glycemic control in type 1 diabetes
$1.0M
The Regents of the University of California Santa Barbara · Santa Barbara, CA · 2024
Exercise specific aid algorithm for type 1 diabetes
$866,199
University Hospitals Health System · Cleveland, OH · 2024
Type 1 diabetes financial toolkit for emerging adults
$794,714
Helmholtz Zentrum Munchen (Gmbh) · 2024
The gppad-04 study supplementation with b. Infantis for mitigation of type 1 diabetes autoimmunity (sint1a)
$608,523
Saint Louis University · Saint Louis, MO · 2024
Identify and validate potential therapeutic targets to prevent hypoglycemia in type 1 diabetes
$600,000
Beyond Type 1 · San Mateo, CA · 2024
Capacity building support
$587,221
Association Sante Diabete · 2024
Strengthen the care and support of patients with type 1 diabetes in mali, burkina faso, and the union of the comoros
$555,000
Beyond Type 1 · San Mateo, CA · 2024
Capacity building support
$543,037
Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2024
U.s. Preventive type 1 diabetes coalition
$502,750
Regents of the University of Minnesota · Minneapolis, MN · 2024
Engineering antigen-specific regulatory t cells for use in type 1 diabetes (phase 3)
$501,000
The Regents of the University of Colorado Denver · Aurora, CO · 2024
T and b cell receptor atlas across tissues and stages of type 1 diabetes
$480,260
American Diabetes Association · Arlington, VA · 2024
2025-2027 type 1 diabetes camp initiative
$431,779
University of Bristol · 2024
Type 1 diabetes risk in adults (t1dra) a general population study
$399,368
American Diabetes Association · Arlington, VA · 2024
2022-2024 type 1 diabetes camp initiative
$385,000
University of Washington · Seattle, WA · 2024
Pathogenic action of autoantibodies on islet function and viability in type 1 diabetes
$375,228
Region Hovedstaden · 2024
Can microchimerism explain differences in parental type 1 diabetes conferred risk of offspring type 1 diabetes?
$374,930
New Venture Fund · Washington, DC · 2024
Type 1 diabetes camps project (2025-2028)
$362,460
Institut National De La Sante Et De La Recherche Medicale · 2024
From benign islet autoimmunity to type 1 diabetes hla-a- vs. Hla-b-restricted cd8 t-cell biomarkers of progression
$300,000
The Regents of the University of Colorado Denver · Aurora, CO · 2024
Mapping the b cell heterogeneity in type 1 diabetes at the single-cell level
$291,029
The Regents of the University of Colorado Denver · Aurora, CO · 2024
Defining human islet myeloid cell populations through progression of type 1 diabetes
$275,000
Vanderbilt University Medical Center · Nashville, TN · 2024
Defining molecular mechanisms of cell dysfunction in type 1 diabetes to develop new approaches to prevent hypoglycemia
$274,391
University of Oulu · 2024
Maternal and paternal type 1 diabetes mechanisms for the distinct recurrence risk in the offspring
$247,813
University of Exeter · 2024
B cell signatures in type 1 diabetes
$227,066
Tampere University Foundation Sr · 2024
Enterovirus-induced type 1 diabetes mechanisms and biomarkers for risk
$206,160
University of Exeter · 2024
Extremely early onset type 1 diabetes (exe t1d) phase 2 from observation to mechanism
$163,405
Vanderbilt University Medical Center · Nashville, TN · 2024
Isolating islets to understand hypoglycemia in type 1 diabetes
$152,801
University of Birmingham · 2024
Defining the efficacy and mechanisms of peptide immunotherapy for type 1 diabetes an experimental medicine study
$151,947
Technische Universitaet Muenchen · 2024
Cost-effectiveness of public health screening for pre-symptomatic type 1 diabetes with and without treatment for prevention of type 1 diabetes
$150,914
The Regents of the University of Colorado Denver · Aurora, CO · 2024
Epigenomic biomarkers of the incomplete maternal protection in type 1 diabetes
$121,999
Vanderbilt University Medical Center · Nashville, TN · 2024
Adapting fams to optimize cgm use among emerging adults with type 1 diabetes
$115,896
The Rector and Visitors of the University of Virginia · Charlottesville, VA · 2024
Type 1 diabetes risk prediction integration of physiology with genetics
$95,777
University of Exeter · 2024
Stimulated glucagon levels as a biomarker of hypoglycemia risk in type 1 diabetes
$62,567
Universite Catholique De Louvain · 2024
Longitudinal study of the glucagon response to hypoglycemia in children and adolescents with new-onset type 1 diabetes
$59,605
Sanford World Clinics · Sioux Falls, SD · 2024
Program detekta detecting type 1 diabetes and preventing diabetic ketoacidosis (dka)
$58,372
Trustees of Indiana University · Bloomington, ID · 2024
Targeting metabolic drivers of b cell differentiation in type 1 diabetes
$55,260
The University of Adelaide · 2024
Pancreatic exocrine function and the progression to type 1 diabetes in young children
$28,108
Medical University of South Carolina · Charleston, SC · 2024
Engineered dendritic cell based robust antigen specific therapy for type 1 diabetes
$2.9M
Helmholtz Zentrum Munchen (Gmbh) · 2023
Continuation of the gppad-02-study: identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$2.1M
Helmholtz Zentrum Munchen (Gmbh) · 2023
Continuation of the gppad-02-study: identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$2.0M
Helmholtz Zentrum Munchen (Gmbh) · 2023
The gppad-05 study: anti-viral action against type 1 diabetes autoimmunity (avant1a)
$1.9M
Vayu Health · Portola Valley, CA · 2023
Vayu health phase 2 - scale and spread of value based payment ecosystem for medicaid beneficiaries living with type 1 and type 2 diabetes
$1.8M
Helmholtz Zentrum Munchen (Gmbh) · 2023
The gppad-04 study: supplementation with b. Infantis for mitigation of type 1 diabetes autoimmunity (sint1a)
$1.5M
New Venture Fund · Washington, DC · 2023
Type 1 diabetes camps project (2022 - 2024)
$1.4M
Jaeb Center for Health Research Foundation · Tampa, FL · 2023
Pregnancy data repository to assess management of type 1 diabetes with diabetes technology (pram-t1d)
$1.4M
Children'S Mercy Hospital · Kansas City, MO · 2023
Type 1 diabetes rapid learning lab
$1.4M
Universite De Geneve · 2023
Preclinical testing of s100a9 to improve glycemic control in type 1 diabetes
$1.3M
The University of Queensland · 2023
Liposomal antigen-specific immunotherapy of recent-onset type 1 diabetes
$1.2M
Panorama Global · Seattle, WA · 2023
Panorama - type 1 diabetes global access micro-grant fund
$1.1M
Beyond Type 1 · San Mateo, CA · 2023
Capacity building support
$1.0M
Helmholtz Zentrum Munchen (Gmbh) · 2023
The gppad-04 study: supplementation with b. Infantis for mitigation of type 1 diabetes autoimmunity (sint1a)
$998,931
University of Pittsburgh · Pittsburgh, PA · 2023
Analogue vs human insulin for youth with type 1 diabetes in low-resource settings: a randomized controlled trial (anhut1d trial)
$998,081
The Aspen Institute · Washington, DC · 2023
Building visionary and effective teams to accelerate progress against type 1 diabetes (t1d) and other non-communicable diseases (ncds)
$940,000
Beyond Type 1 · San Mateo, CA · 2023
Capacity building support
$832,906
The Regents of the University of California Santa Barbara · Santa Barbara, CA · 2023
Exercise specific aid algorithm for type 1 diabetes
$707,339
University Hospitals Health System · Cleveland, OH · 2023
Type 1 diabetes financial toolkit for emerging adults
$669,554
University of Exeter · 2023
Uncovering new genetic mechanisms underlying extreme early-onset type 1 diabetes
$648,749
The Regents of the University of California San Francisco · San Francisco, CA · 2023
Identification and analysis of extreme forms of type 1 diabetes, establishment of a data commons
$608,000
Saint Louis University · Saint Louis, MO · 2023
Identify and validate potential therapeutic targets to prevent hypoglycemia in type 1 diabetes
$556,499
Albert Einstein College of Medicine · Bronx, NY · 2023
Preclinical activities to advance d-peptides as an antigen-specific immunotherapy for type 1 diabetes
$506,886
University of Birmingham · 2023
Creating an optimised antigen-specific immunotherapy for type 1 diabetes
$502,750
Regents of the University of Minnesota · Minneapolis, MN · 2023
Engineering antigen-specific regulatory t cells for use in type 1 diabetes (phase 3)
$501,000
The Regents of the University of Colorado Denver · Aurora, CO · 2023
T and b cell receptor atlas across tissues and stages of type 1 diabetes
$500,000
University of Cambridge · 2023
Closed loop insulin delivery in newly diagnosed youth with type 1 diabetes ages 10 to 18 years (part 2)
$494,612
Albert Einstein College of Medicine · Bronx, NY · 2023
Preclinical activities to advance d-peptides as an antigen-specific immunotherapy for type 1 diabetes
$412,500
Medical University of South Carolina · Charleston, SC · 2023
Engineered dendritic cell based robust antigen specific therapy for type 1 diabetes
$399,368
American Diabetes Association · Arlington, VA · 2023
2022-2024 type 1 diabetes camp initiative
$345,527
University of Exeter · 2023
Extremely early onset type 1 diabetes (exe t1d) phase 2: from observation to mechanism
$307,674
University of Exeter · 2023
Stimulated glucagon levels as a biomarker of hypoglycemia risk in type 1 diabetes
$300,000
The Regents of the University of Colorado Denver · Aurora, CO · 2023
Mapping the b cell heterogeneity in type 1 diabetes at the single-cell level
$275,000
The University of Texas Southwestern Medical Center · Dallas, TX · 2023
Immune checkpoint engineered beta cell as an antigen-specific immunotherapy for the treatment of type i diabetes
$251,607
University of Exeter · 2023
B cell signatures in type 1 diabetes
$217,136
The University of Adelaide · 2023
Pancreatic exocrine function and the progression to type 1 diabetes in young children
$210,829
Technische Universitat Dresden · 2023
Genomic influence of maternal type 1 diabetes - understanding protection against type 1 diabetes
$206,088
The Rector and Visitors of the University of Virginia · Charlottesville, VA · 2023
Type 1 diabetes risk prediction: integration of physiology with genetics
$200,000
Vanderbilt University Medical Center · Nashville, TN · 2023
Isolating islets to understand hypoglycemia in type 1 diabetes
$179,714
The University of Edinburgh · 2023
Understanding alpha cell dysfunction and correcting glucagon secretion in type 1 diabetes.
$170,401
Vanderbilt University Medical Center · Nashville, TN · 2023
Defining molecular mechanisms of cell dysfunction in type 1 diabetes to develop newapproaches to prevent hypoglycemia
$159,623
The University of Edinburgh · 2023
Understanding alpha cell dysfunction and correcting glucagon secretion in type 1 diabetes.
$157,700
The Regents of the University of Colorado Denver · Aurora, CO · 2023
Diabetic ketoacidosis trends and resource utilization at diagnosis of type 1 diabetes in the united states
$149,166
Beyond Type 1 · San Mateo, CA · 2023
Diabetic ketoacidosis (dka) campaign phase 3
$146,368
President and Fellows of Harvard College · Cambridge, MA · 2023
Pre-symptomatic autoantibody and viral profile of us military personnel with adult-onset type 1 diabetes
$137,453
University of Oulu · 2023
Maternal and paternal type 1 diabetes mechanisms for the distinct recurrence risk in the offspring
$127,031
Technische Universitaet Muenchen · 2023
Cost-effectiveness of public health screening for pre-symptomatic type 1 diabetes with and without treatment for prevention of type 1 diabetes
$91,848
University of Toledo · Toledo, OH · 2023
Type 1 diabetes car treg therapeutic approach
$80,506
University of Birmingham · 2023
Defining the efficacy and mechanisms of peptide immunotherapy for type 1 diabetes: an experimental medicine study
$68,349
Vanderbilt University Medical Center · Nashville, TN · 2023
Adapting fams to optimize cgm use among emerging adults with type 1 diabetes
$64,900
Panorama Global · Seattle, WA · 2023
Panorama - type 1 diabetes global access micro-grant fund
$36,595
Vanderbilt University Medical Center · Nashville, TN · 2023
Isolating islets to understand hypoglycemia in type 1 diabetes
$18,632
University of Toledo · Toledo, OH · 2023
Type 1 diabetes car treg therapeutic approach
$3.0M
Children'S Mercy Hospital · Kansas City, MO · 2022
Type 1 diabetes rapid learning lab
$2.1M
Helmholtz Zentrum Munchen (Gmbh) · 2022
Identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$1.7M
University of Kansas Center for Research · Lawrence, KS · 2022
Preclinical development to advance a type 1 diabetes antigen-specific immunotherapy called saga-t1d
$1.4M
New Venture Fund · Washington, DC · 2022
Type 1 diabetes camps project (2022 - 2024)
$1.4M
Helmholtz Zentrum Munchen (Gmbh) · 2022
The gppad-04 study: supplementation with b. Infantis for mitigation of type 1 diabetes autoimmunity (sint1a)
$1.3M
University of Pittsburgh · Pittsburgh, PA · 2022
Analogue vs human insulin for youth with type 1 diabetes in low-resource settings: a randomized controlled trial (anhut1d trial).
$1.2M
University of Florida · Gainesville, FL · 2022
The network for pancreatic organ donors with diabetes (npod): a collaborative type 1 diabetes research project
$999,473
Panorama Global · Seattle, WA · 2022
Panorama - type 1 diabetes global access micro-grant fund
$996,251
The Aspen Institute · Washington, DC · 2022
Building visionary and effective teams to accelerate progress against type 1 diabetes (t1d) and other non-communicable diseases (ncds)
$765,477
Saint Louis University · Saint Louis, MO · 2022
Identify and validate potential therapeutic targets to prevent hypoglycemia in type 1 diabetes
$697,881
Helmholtz Zentrum Munchen (Gmbh) · 2022
Identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$691,810
Helmholtz Zentrum Munchen (Gmbh) · 2022
The gppad-04 study: supplementation with b. Infantis for mitigation of type 1 diabetes autoimmunity (sint1a)
$556,046
Chancellor Masters & Scholars of the University of Oxford · 2022
Alpha cell function in people with type 1 diabetes with and without severe hypoglycemia
$546,306
Chancellor Masters & Scholars of the University of Oxford · 2022
Pharmacological modulation to restore counterregulatory glucagon secretion in type 1 diabetes
$496,568
University of Cambridge · 2022
Closed loop insulin delivery in newly diagnosed youth with type 1 diabetes ages 10 to 18 years (part 2)
$433,333
The Regents of the University of California San Francisco · San Francisco, CA · 2022
Identification and analysis of extreme forms of type 1 diabetes, establishment of patient registry
$407,937
University of Bristol · 2022
Type 1 diabetes risk in adults (t1dra) a general population study
$382,594
Michigan State University · East Lansing, MI · 2022
A c-peptide complex for improved glucose metabolism in people with type 1 diabetes
$330,758
The Regents of the University of Colorado Denver · Aurora, CO · 2022
Diabetic ketoacidosis trends and resource utilization at diagnosis of type 1 diabetes in the united states
$322,498
University of Birmingham · 2022
Defining the efficacy and mechanisms of peptide immunotherapy for type 1 diabetes: an experimental medicine study
$300,000
The Regents of the University of Colorado Denver · Aurora, CO · 2022
Mapping the b cell heterogeneity in type 1 diabetes at the single-cell level
$275,000
The University of Texas Southwestern Medical Center · Dallas, TX · 2022
Immune checkpoint engineered beta cell as an antigen-specific immunotherapy for the treatment of type i diabetes
$275,000
Vanderbilt University Medical Center · Nashville, TN · 2022
Defining molecular mechanisms of cell dysfunction in type 1 diabetes to develop new approaches to prevent hypoglycemia
$274,787
President and Fellows of Harvard College · Cambridge, MA · 2022
Pre-symptomatic autoantibody and viral profile of us military personnel with adult-onset type 1 diabetes
$267,694
Hannoversche Kinderheilanstalt · 2022
Fr1da in northern germany: pre-symptomatic type 1 diabetes testing in children
$261,908
T1d Exchange · Boston, MA · 2022
A data driven approach to improve quality and outcomes for individuals with type 1 diabetes
$250,000
Regents of the University of Minnesota · Minneapolis, MN · 2022
Phase 2: engineering antigen-specific regulatory t cells for use in type 1 diabetes
$227,950
Ideoorg · San Francisco, CA · 2022
Human-centered design study of type 1 diabetes in medically underserved communities in the u.s.
$220,000
University of Washington · Seattle, WA · 2022
Pathogenic action of autoantibodies on islet function and viability in type 1 diabetes
$211,526
The Rector and Visitors of the University of Virginia · Charlottesville, VA · 2022
Type 1 diabetes risk prediction: integration of physiology with genetics
$200,000
Ideoorg · San Francisco, CA · 2022
Human-centered design study of type 1 diabetes in medically underserved communities in the u.s.
$164,338
Institut Nationale De La Sante Et De La Recherche Medicale · 2022
From benign islet autoimmunity to type 1 diabetes: mechanistic cd8+ t-cell biomarkers of progression
$157,744
University of Exeter · 2022
Stimulated glucagon levels as a biomarker of hypoglycemia risk in type 1 diabetes
$149,167
Beyond Type 1 · San Mateo, CA · 2022
Diabetic ketoacidosis (dka) campaign phase 3
$140,766
Vanderbilt University Medical Center · Nashville, TN · 2022
Adapting fams to optimize cgm use among emerging adults with type 1 diabetes
$114,365
Trustees of Indiana University · Bloomington, MI · 2022
Targeting metabolic drivers of b cell differentiation in type 1 diabetes
$104,349
Region Hovedstaden · 2022
Can microchimerism explain differences in parental type 1 diabetes conferred risk of offspring type 1 diabetes?
$30,509
University of Exeter · 2022
Stimulated glucagon levels as a biomarker of hypoglycemia risk in type 1 diabetes
$3.3M
New Venture Fund · Washington, DC · 2021
Type 1 diabetes camps project (2022 - 2024)
$2.0M
Children'S Mercy Hospital · Kansas City, MO · 2021
Type 1 diabetes rapid learning lab
$833,440
Panorama Global · Seattle, WA · 2021
Type 1 diabetes global access micro-grant fund
$615,166
University of Exeter · 2021
Understanding extremely early-onset type 1 diabetes
$451,667
Beyond Type 1 · San Carlos, CA · 2021
Diabetic ketoacidosis (dka) campaign phase 3
$445,112
Children'S Mercy Hospital · Kansas City, MO · 2021
Type 1 diabetes rapid learning lab
$331,219
American Diabetes Association · Arlington, VA · 2021
2022-2024 type 1 diabetes camp initiative
$305,030
Tampere University Foundation Sr · 2021
Viruses and antiviral immune markers in two endotypes of type 1 diabetes
$286,700
Hannoversche Kinderheilanstalt · 2021
Fr1da in north germany: pre-symptomatic type 1 diabetes testing in kids
$241,490
The Rector and Visitors of the University of Virginia · Charlottesville, VA · 2021
Type 1 diabetes risk prediction: integration of physiology with genetics
$200,000
Vanderbilt University Medical Center · Nashville, TN · 2021
Isolating islets to understand hypoglycemia in type 1 diabetes
$110,480
University of Toledo · Toledo, OH · 2021
Type 1 diabetes car treg therapeutic approach
$102,647
University of Birmingham · 2021
Antigen specific immunotherapy in type 1 diabetes
$102,000
New Venture Fund · Washington, DC · 2021
Type 1 diabetes camps project (2022 - 2024)
$14,355
Clinical Data Interchange Standards Consortium · Austin, TX · 2021
Cdisc standards development project for type 1 diabetes

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

Helmholtz Zentrum Munchen (Gmbh)42 grants · $52.3M
Blue Circle Health11 grants · $45.4M
Shaare Zedek Medical Center22 grants · $42.6M
Clalit Health Services37 grants · $41.7M
American Heart Association20 grants · $30.7M
Regents of the University of Minnesota16 grants · $30.4M
The End Fund4 grants · $30.0M
The Regents of the University of Colorado Denver49 grants · $22.5M
Mass General Brigham for the Brigham and Women'S Hospital7 grants · $21.5M
Catholic Relief Services-Usccb13 grants · $21.4M

Giving over time

$382.7M

2021

$427.5M

2022

$440.0M

2023

$439.5M

2024

Grant history

The 100 largest of 2,251 grants.

$22.5M
The End Fund · New York, NY · 2022
Neglected tropical disease: reaching the last mile
$15.6M
Blue Circle Health · Wilmington, DE · 2021
Creation of blue circle health for underserved communities with t1d
$12.6M
Regents of the University of Minnesota · Minneapolis, MN · 2021
Minnesota first responder aed project
$9.9M
Shaare Zedek Medical Center · 2021
The helmsley cancer center at shaare zedek medical center jerusalem
$9.0M
Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2023
Pen-plus expansion
$7.0M
Engineering Ministries International USA · Colorado Springs, CO · 2022
Alaska wash project
$7.0M
American Heart Association · Dallas, TX · 2024
American heart association center for telehealth
$6.8M
Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2024
Accelerating progress and promoting quality t1d care for the poorest billion through the global pen-plus partnership
$6.7M
Engineering Ministries International USA · Colorado Springs, CO · 2021
Alaska wash project
$6.6M
Nevada Department of Health and Human Services · Carson City, NV · 2022
Nevada first responder aed project
$6.6M
Geoscience Australia · 2022
Digital earth africa - sustainable uptake and impact
$6.4M
Commonwealth Healthcare Corporation · 2023
Cnmi chcc mri/medical equipment upgrade project
$6.1M
Yitzhak Shamir Medical Center · 2022
Expansion and renovation of the cancer institute at shamir medical center
$5.8M
Ben-Gurion University of the Negev · 2024
Construction of the leona m. And harry b. Helmsley charitable trust computer science building
$5.7M
Brigham and Women'S Hospital · Boston, MA · 2022
Pen-plus expansion
$5.6M
Nebraska Department of Health & Human Services · Lincoln, NE · 2021
Nebraska first responder aed project
$5.4M
Tzafon Medical Center · 2023
The helmsley rehabilitation center of the north
$5.3M
Iowa Department of Public Health · Des Moines, IA · 2021
Iowa first responder aed initiative
$5.3M
Hadassah Medical Organization · 2024
Equipping the new hadassah - helmsley medical center, netivot
$5.3M
Bridges To Prosperity · Denver, CO · 2021
Transformative connectivity in rural ethiopia
$5.2M
Shaare Zedek Medical Center · 2022
The helmsley cancer center at shaare zedek medical center jerusalem
$5.2M
Shaare Zedek Medical Center · 2023
Linear accelerators for the radiotherapy institute
$5.1M
The Baruch Padeh Medical Center Poriya · 2021
The helmsley rehabilitation center of the north
$5.0M
Regents of the University of Minnesota · Minneapolis, MN · 2022
Redefining the future of emergency medicine
$5.0M
Billings Clinic Foundation · Billings, MT · 2024
Billings clinic surgical intensive care unit
$5.0M
Kapiolani Health Foundation · Honolulu, HI · 2024
Martha b. Smith cancer & infusion center at kapiolani medical center for women & children
$5.0M
Stichting the Ocean Cleanup · 2024
Develop and scale technologies to rid the oceans of plastics
$5.0M
The Queens Medical Center · Honolulu, HI · 2024
The queen's medical center - west oahu cancer center expansion
$5.0M
Shaare Zedek Medical Center · 2023
Development of the helmsley surgical wing
$5.0M
Stichting the Ocean Cleanup · 2023
Develop and scale technologies to rid the oceans of plastics
$5.0M
Civica Foundation · Lehi, UT · 2021
Affordable insulin biosimilars
$4.9M
St Rose Dominican Health Foundation · Henderson, NV · 2023
Dignity health - st. Rose dominican - siena campus ecmo program
$4.9M
Fairview Health Services · Minneapolis, MN · 2023
Improving survival outcomes through university of minnesota medical center ecmo center of excellence
$4.9M
Regents of the University of Minnesota · Minneapolis, MN · 2023
Minnesota first responder aed project
$4.9M
Tel Aviv Sourasky Medical Center - Ichilov Hospital · 2024
Construction of the sheltered -5 floor of the north tower
$4.5M
Baptist Medical Centre · 2024
Elevating maternal and pediatric healthcare
$4.5M
Blue Circle Health · Wilmington, DE · 2024
Development of blue circle health
$4.5M
Blue Circle Health · Wilmington, DE · 2024
Development of blue circle health
$4.5M
The Baruch Padeh Medical Center Poriya · 2022
The helmsley rehabilitation center of the north
$4.4M
World Health Organization · 2022
Strengthening the capacity of the global diabetes compact
$4.4M
The Sheba Fund for Health Services and Research (Ra) · 2023
The helmsley center for innovative surgical training
$4.2M
Altru Health System · Grand Forks, ND · 2024
Altru health system ultrasound initiative
$4.2M
American Heart Association · Dallas, TX · 2023
American heart association center for telehealth
$4.2M
Jerusalem College of Technology · 2022
Helmsley faculty of life and health sciences building
$4.1M
The End Fund · New York, NY · 2023
Reaching the last mile fund expansion
$4.1M
Zefat Academic College · 2021
Equipping zefat academic college's inst. For adv. Health training & ed.
$4.1M
Clalit Health Services · 2022
A new neonatal center for israels southern periphery at soroka medical center
$4.0M
Holy Rosary Healthcare Foundation · Miles City, MT · 2022
Holy rosary healthcare comprehensive cancer center
$4.0M
Blue Circle Health · Wilmington, DE · 2024
Development of blue circle health
$3.9M
Wilcox Health Foundation · Lihue, HI · 2024
Wilcox medical center equipment revitalization project
$3.9M
Clalit Health Services · 2021
Medical equipment for carmel medical center in haifa, israel
$3.9M
Hadassah Medical Organization · 2022
Creating and equipping a new comprehensive diagnostic and interventional imaging center
$3.8M
Clalit Health Services · 2022
Yoseftal hospital addition
$3.8M
St Alexius Medical Center · Bismarck, ND · 2024
Chi st. Alexius health ultrasound initiative
$3.7M
New York University School of Medicine · New York, NY · 2023
Tamale education and innovation center for health
$3.7M
Central Montana Medical Facilities · Lewistown, MT · 2023
Cancer center at central montana medical center
$3.7M
T1d Exchange · Boston, MA · 2021
Data approach to improve quality and outcomes for individuals with t1d
$3.7M
Bhsh System · Grand Rapids, MI · 2022
Study the feasibility of telerobotic heart attack and stroke interventions
$3.7M
Helmholtz Zentrum Munchen (Gmbh) · 2021
Identification of infants with high risk of t1d - primary prevention
$3.6M
The Sheba Fund for Health Services and Research (Ra) · 2022
The helmsley center for innovative surgical training
$3.5M
Hillel Yaffe Medical Center · 2024
Construction of pet-ct institute
$3.5M
Maccabi Healthcare Services · 2021
Da vinci 4xi system dual console surgical robot and sterilization equip.
$3.5M
State of Nevada Department of Division of State Parks · Carson City, NV · 2024
Valley of fire visitor center
$3.5M
State of Nevada Department of Division of State Parks · Carson City, NV · 2023
Ice age fossil state park trails and outdoor amenities
$3.5M
State of Nevada Department of Division of State Parks · Carson City, NV · 2023
Valley of fire visitor center
$3.5M
Blue Circle Health · Wilmington, DE · 2022
Development of blue circle health
$3.5M
The Broad Institute · Cambridge, MA · 2024
Novel therapeutic approaches for crohns disease
$3.5M
Blue Circle Health · Wilmington, DE · 2023
Development of blue circle health
$3.5M
Indiana University · Indianapolis, IN · 2021
Ampath model replication in ghana
$3.5M
Central Montana Medical Facilities · Lewistown, MT · 2022
Cancer center at central montana medical center
$3.3M
Bar Ilan University in Israel · 2024
The leona m. And harry b. Helmsley energy prototype lab at bar-ilan university
$3.3M
New Venture Fund · Washington, DC · 2021
Type 1 diabetes camps project (2022 - 2024)
$3.3M
St Luke Health Care Foundation · West Chicago, IL · 2024
Hope center for women and children
$3.2M
Bar Ilan University · 2023
The leona m. And harry b. Helmsley energy prototype lab at bar-ilan university
$3.2M
Fairview Health Services · Minneapolis, MN · 2024
Improving survival outcomes through university of minnesota medical center ecmo center of excellence
$3.2M
Hillel Yaffe Medical Center · 2024
Eye institute and ambulatory surgery center
$3.1M
National Park Foundation · Washington, DC · 2022
Little bighorn battlefield national monument visitor center
$3.1M
World Health Organization · 2024
Strengthening the capacity of the global diabetes compact
$3.1M
World Health Organization · 2024
Strengthening integrated prevention and control of chronic and severe ncds in the who african region, using t1d, scd, arf, and rhd as entry points
$3.1M
Renown Health Foundation · Reno, NV · 2022
Simulation and innovation center at renown health
$3.1M
Clinton Health Access Initiative · Boston, MA · 2023
Improving medical oxygen production and utilization
$3.0M
Brigham and Women'S Hospital · Boston, MA · 2021
Global partnership to achieve universal access for t1d and ncds
$3.0M
St Luke Health Care Foundation · West Chicago, IL · 2023
Hope center for women and children
$3.0M
Trinity Health · Minot, ND · 2024
Trinity health ultrasound initiative
$3.0M
The Weizmann Institute of Science · 2024
Early childhood development and community center at the weizmann institute of science
$3.0M
Tel-Aviv University · 2023
Helmsley medical simulation center
$3.0M
The Weizmann Institute of Science · 2023
Early childhood development and community center at the weizmann institute of science
$3.0M
Diabetes Nsw · 2022
Improvements in outcomes for young people with diabetes in less-resourced countries
$3.0M
The Jewish Agency for Israel · 2022
Flights for new immigrants from russia
$3.0M
Avera McKennan Hospital and University Health Center · Sioux Falls, SD · 2021
Avera behavioral health center expansion
$3.0M
Jdrf T1d Fund Llc · Boston, MA · 2021
Jdrf t1d fund phase iii
$3.0M
South Dakota Parks & Wildlife Foundation · Pierre, SD · 2021
Custer state park bison center
$3.0M
The Broad Institute · Cambridge, MA · 2021
Novel therapeutic approaches for crohns disease
$3.0M
Children'S Mercy Hospital · Kansas City, MO · 2022
Type 1 diabetes rapid learning lab
$3.0M
Kmr Advancement of Medical Centers Ltd · 2021
Establishment of the health discovery tower
$2.9M
Helmholtz Zentrum Munchen (Gmbh) · 2023
Continuation of the gppad-02-study: identification of infants with increased type 1 diabetes risk for enrollment into primary prevention trials
$2.9M
Mass General Brigham for the Brigham and Women'S Hospital · Boston, MA · 2024
Real-time post-op touchless, remote monitoring in crohns disease the sapphire trial
$2.9M
Sanford · Fargo, ND · 2022
Sanford health ultrasound project
$2.9M
World Health Organization · 2023
Strengthening integrated prevention and control of chronic and severe ncds in the who african region, using t1d, scd, arf, and rhd as entry points
$2.9M
Jerusalem College of Technology · 2021
Helmsley faculty of life and health sciences building

View all 2,251 grants →

Who else funds this kind of work

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.